false
0000820313
0000820313
2026-05-21
2026-05-21
0000820313
us-gaap:CommonClassAMember
2026-05-21
2026-05-21
0000820313
us-gaap:CommonClassBMember
2026-05-21
2026-05-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 21, 2026
AMPHENOL CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware |
|
1-10879 |
|
22-2785165 |
(State
or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
| 358
Hall Avenue, Wallingford,
Connecticut |
|
06492 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: (203)
265-8900
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
| Title of
each class |
Trading Symbol(s) |
Name of each
exchange on which registered |
| Class A Common Stock, $0.001 par value |
APH |
New York Stock Exchange |
| 3.125% Senior Notes due 2032 |
APH32 |
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth
company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.07 Submission of Matters to a Vote
of Security Holders.
The annual meeting of stockholders of Amphenol
Corporation (the “Company”) was held on May 21, 2026. As of March 23, 2026, the record date for the meeting,
1,229,430,709 shares of Class A Common Stock, par value $.001 per share (“Common Stock”) were outstanding. A quorum
of 1,121,383,291 shares were present or represented at the meeting.
The stockholders (i) elected each of
the Company’s nominees for director, (ii) ratified the selection of Deloitte & Touche LLP as independent public accountants
of the Company, and (iii) approved the advisory vote to approve compensation of named executive officers. The voting results
for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on
April 8, 2026, are as follows:
| 1. |
ELECTION OF EIGHT DIRECTORS |
FOR the
nominees:
| NOMINEE | |
FOR | | |
AGAINST | | |
ABSTAIN | | |
NON-VOTES | |
| Nancy A. Altobello | |
1,060,354,260 | | |
12,136,716 | | |
226,738 | | |
48,665,577 | |
| David P. Falck | |
1,019,588,710 | | |
51,238,137 | | |
1,890,867 | | |
48,665,577 | |
| Sanjiv Lamba | |
1,061,622,681 | | |
10,849,424 | | |
245,609 | | |
48,665,577 | |
| Rita S. Lane | |
1,066,823,967 | | |
5,662,734 | | |
231,013 | | |
48,665,577 | |
| Robert A. Livingston | |
1,043,851,235 | | |
28,626,974 | | |
239,505 | | |
48,665,577 | |
| R. Adam Norwitt | |
1,014,364,065 | | |
58,062,011 | | |
291,638 | | |
48,665,577 | |
| Prahlad Singh | |
1,063,901,047 | | |
8,572,596 | | |
244,071 | | |
48,665,577 | |
| Anne Clarke Wolff | |
1,064,478,936 | | |
8,011,199 | | |
227,579 | | |
48,665,577 | |
| 2. |
RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS |
| FOR | |
1,048,449,127 | |
AGAINST | |
72,154,410 | |
| | |
| |
| |
| |
| ABSTAIN | |
779,754 | |
NON-VOTES | |
0 | |
| 3. | ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE
OFFICERS |
| FOR | |
984,297,730 | |
AGAINST | |
83,096,067 | |
| | |
| |
| |
| |
| ABSTAIN | |
5,323,917 | |
NON-VOTES | |
48,665,577 | |
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
|
Document Description |
| |
|
|
| 104 |
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
AMPHENOL CORPORATION |
| |
|
|
| |
By: |
/s/ Lance E. D’Amico |
| |
|
Lance E. D’Amico |
| |
|
Executive Vice President, Secretary and General Counsel |
| |
|
|
| Date: May 22, 2026 |
|
|